The circKIF4A-miR-335-OCT4/ALDOA-HK2/PKM2 axis was shown in this work to be essential for the metabolic reprogramming of breast cancer, suggesting that this axis may represent a potential therapeutic target for the treatment of liver metastases of breast cancer [123]. Here, PKM is linked to breast carcinoma.